复方水蛭精胶囊治疗经皮冠状动脉成形术后再狭窄36例

Treatment Outcome on Restenosis after Percutaneous Transluminal Coronary Angioplasty Experience Treated with Fufangshuizhijing Capsule

摘要:

探索观察复方中药制剂对经皮冠状动脉成形术后再狭窄的临床疗效。复方水蛭精胶囊对患者血脂水平胆固醇(Tch)影响不明显,而对甘油三酯(TG)和低密度脂蛋白(LDL-C)影响显著。对心率变异以及心脏功能临床评价也明显优于对照组,特别是左室射血分数(LVEF)及冠状动脉病变支数有明显改善。结论:复方中药制剂在治疗PTCA术后或冠心病心血管病变方面具有很大潜力,可替代单味药作用单一,剂量不足以及长期疗效稳定性差的缺点。

Abstract:

To observate the clinical effect of Fufangshuizhijing Capsule treating restenosis after Percutaneous transluminal coronary angioplasty, the results showed significant change of TG Level and LDL-C level with Fufangshuizhijing capsule orally, but no significant change for total cholesterol level. The capsule is also better for improving HRV and heart function, especially, left ventricular ejection fraction and coronary vessels disease.